🇺🇸 FDA
Pipeline program

A clinical study of MK-6916 and placebo in healthy people (MK-6916-003)

MK-6916-003

Phase 1 other active

Quick answer

A clinical study of MK-6916 and placebo in healthy people (MK-6916-003) for Acute and chronic Pain is a Phase 1 program (other) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).

Program details

Company
Merck Sharp and Dohme
Indication
Acute and chronic Pain
Phase
Phase 1
Modality
other
Status
active

Clinical trials